Number of Shares
426,700.00
Current Holdings Value*
$29.45 Mil
% of Portfolio
3.12%
Total Estimate Gain
$-16.07 Mil
% of Total Estimate Gain
-36.81%

GuoLine Advisory Pte Ltd's Novo Nordisk AS Holding Summary

As of 2025-06-30, GuoLine Advisory Pte Ltd held 426,700.00 shares of Novo Nordisk AS(NVO), totaling $29.45 Mil. This investment constitutes 3.12% of their stock portfolio, and GuoLine Advisory Pte Ltd now holds 0.01% of the outstanding Novo Nordisk AS(NVO) stock.

The initial trade took place in 2023Q4. And since then GuoLine Advisory Pte Ltd has made 4 purchases of NVO, at an average price of $102.28, for a total of 426,700.00 shares. Based on historical transaction data and NVO's current price of $64.62, GuoLine Advisory Pte Ltd's estimated gain on his NVO holdings is $-16.07 Mil, reflecting a -36.81% gain to date.

GuoLine Advisory Pte Ltd NVO ($64.62) Holding Chart

GuoLine Advisory Pte Ltd NVO ($64.62) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1